跳至主要内容
临床试验/NCT06500741
NCT06500741已完成不适用

Discrete Choice Experiment to Assess the Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Patients With Prostate Cancer

Astellas Pharma Global Development, Inc.1 个研究点 分布在 1 个国家目标入组 374 人开始时间: 2024年11月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
374
试验地点
1
主要终点
Patients' Preference weights for different treatment attributes

研究概览

简要总结

The purpose of this study is to quantify the preferences for novel hormonal therapy (NHT) +/- androgen-deprivation therapy (ADT) vs ADT monotherapy among patients with non-metastatic hormone-sensitive prostate cancer (PC) in the United States (US), Germany, Spain, France, Italy, the United Kingdom (UK), South Korea, Australia, and Brazil, using a discrete choice experiment (DCE).

详细描述

The study will collect data from eligible patients (six total) and physicians (six total) from one-on-one qualitative interviews and eligible patients from online surveys. Approximately 330 patients with PC will be recruited to complete the online DCE survey.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Physician inclusion criteria
  • The physician is a certified urologist or oncologist. The final selection will be adjusted to local practice.
  • The physician has cared for at least ten nmHSPC patients in the past year.
  • The physician has experience prescribing NHT and ADT. Patient inclusion criteria
  • The patient has nmHSPC after radiotheraphy (RT) and/or radical prostatectomy (RP), defined as an adult patient with nmPC who had RT and/or RP.

排除标准

  • Physician exclusion criteria
  • None Patient exclusion criteria
  • The patient is castration resistant.
  • The patient has metastatic PC.

结局指标

主要结局

Patients' Preference weights for different treatment attributes

时间窗: Up to 1 day

Preference data will be collected via online survey questionnaires designed using DCE method.

Patients' Overall Preference for a specific treatment profile (NHT +/- ADT or ADT monotherapy)

时间窗: Up to 1 day

Preference data will be collected via online survey questionnaires designed using DCE method.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Experiment to Assess Preferences for Novel Hormonal... | 临床试验